Providers/Grant Support
Jointly provided by UK HealthCare CECentral and DKBmed, LLC.
This activity is supported by an educational grant from Lilly.
Credits Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity is designed to meet the educational needs of primary care providers.
Program Overview
Alzheimer’s disease affects more than 7 million people in the U.S. and is expected to double by 2060. Critically, many racial and ethnic disparities exist along the entire Alzheimer’s care continuum.
Watch our webinar to improve early detection and equitable care in your practice. We’ll cover:
- How to recognize and assess cognitive impairment.
- Disparities in Alzheimer’s disease based on socioeconomic, race, gender, and other demographic factors
- New diagnostic tools like blood-based biomarkers.
- The latest on disease-modifying treatments.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the variation in AD prevalence across race, gender, and other demographic factors.
- Identify and interpret emerging diagnostic tools that can facilitate earlier and more accurate diagnosis of AD.
- Evaluate clinical appropriateness of available disease-modifying treatments for AD.
- Apply best practices for communicating about dementia and screening for AD with patients and caregivers, with sensitivity to cultural, emotional, and systemic barriers.
Faculty
Gregory Jicha, MD, PhD
University of Kentucky
Professor of Neurology
Director, UK Telemedicine Cognitive Clinic
Alzheimer’s Disease Center at Sanders-Brown Center on Aging
Frederick A. Schmitt, PhD
University of Kentucky
Professor of Neurology, Neurosurgery, Psychiatry, Behavioral Science, and Psychology
Alzheimer’s Disease Center at Sanders-Brown Center on Aging
Bobbie Adams, APRN
Neurology APRN, Family APRN, and MAT APRN at Family Health Care Clinic, PSC.
Accreditation Statement
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation
This Enduring activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
1.00 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).
1.00 Participation
UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Disclosures of Conflict of Interest
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
To access activities, users will need:
- A computer with an internet connection
- An HTML5 compliant web browser or Internet Explorer 8 (and higher)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating and receiving CME/CE credit for this activity.
Contact Information
For additional information about the accreditation of this activity, please visit CE Central.